Skip to content
2000
Volume 6, Issue 3
  • ISSN: 1573-3971
  • E-ISSN: 1875-6360

Abstract

Gadolinium based contrast agents (GBCAs) have been linked to nephrogenic systemic fibrosis (NSF) in patients with severe renal dysfunction. This article reviews strategies to prevent this condition in patients at risk. These include administering only single dose GBCA, scheduling MRI for just before the next routine dialysis in dialysis patients, delaying GBCA in acute renal failure while serum creatinine is rising, and making sure the best technologist is doing the case to ensure it will not need repeating. Most MRI centers have implemented at least some these NSF risk reduction strategies and as a result, NSF incidence is markedly decreased.

Loading

Article metrics loading...

/content/journals/crr/10.2174/157339710791792766
2010-08-01
2025-05-19
Loading full text...

Full text loading...

/content/journals/crr/10.2174/157339710791792766
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test